The clinical research program at Intermountain Health's St. Vincent Regional Hospital has come a long way since its inception ...

This is a multicenter, open-label, dose-ranging study with 3 cohorts in the dose-escalation portion assessing safety of OCU200 and in the fourth cohort a combination of OCU200 (MTD) with anti-VEGF ...

Results of the first phase of the Ceramide Ring Trial have been published in Nature Communications, representing a ...

Opinion: An upcoming FDA ad comm on a treatment for the ultra rare Barth syndrome can’t use the normal measuring sticks for ...

Ocugen (OCGN) reported that the FDA has lifted the clinical hold on the investigational new drug application for the Phase 1 clinical ...

Ocugen said the Food and Drug Administration lifted a clinical hold on its OCU200 investigational treatment for diabetic macular edema, paving the way for Phase 1 trials.

Ocugen (NASDAQ:OCGN) said the FDA has removed a clinical hold on its Investigational New Drug application for a Phase 1 study ...

Boehringer Ingelheim has received a breakthrough therapy designation from the US Food and Drug Administration (FDA) for ...

The purpose of this online study is to investigate how romantic relationships during undergraduate studies influence young women’s ... associate professor in the Department of Veterinary Clinical ...

The evolving landscape of environmental, climate, and energy policy is marked by both pressing global challenges as well as opportunities for transformative action. Here, we discuss emerging ...

Here’s what to expect: Head-to-head trials always carry high risk. Any company that sponsors one is doing so with the knowledge testing could reveal its drug is equivalent to a competitor or, worse, ...

Destiny 2’s pinnacle PVP activity, Trials of Osiris, returns yet again. If you want to know what this week’s featured map and weapon are, we have all that and more in this breakdown of the ...